Can four simple diet hacks boost digital weight loss? stanford launches reset trial

NCT ID NCT07032571

First seen Jun 24, 2026 · Last updated Aug 05, 2026 · Updated 4 times

Summary

The Reset trial, led by Stanford University, aims to find the best combination of four dietary strategies for weight loss in a fully digital program. 208 adults with overweight or obesity will receive a 12-week remote intervention that includes daily self-weighing, weekly lessons, and tailored feedback. Participants will be assigned to limit red zone foods, limit eating windows, increase protein, or increase fiber—or a mix. The study uses a special framework to identify which combination works best, with weight change measured at 1 and 3 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
behavioral weight loss intervention with dietary strategies (limiting red zone foods, limiting eating windows, increasing protein, increasing fiber)
What this could lead to
If successful, this could identify the best combination of simple dietary strategies for effective weight loss in a fully digital program.
What could go wrong
This is a small, early-stage optimization trial (not a test of a new drug), so results may not apply broadly. Weight loss depends on individual adherence, and the study is not designed to prove long-term effectiveness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTH BEHAVIOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Body Weight Body Weight Changes Health Behavior Obesity obesity disorder Overweight Weight Loss

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Stanford University School of Medicine

    Palo Alto, California, 94304, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.